The Future of Transatlantic Collaboration in Biopharma and MedTech Post-Pandemic





Nov 9, 2021


The Future of Transatlantic Collaboration in Biopharma and MedTech Post-Pandemic

November 9, 2021
8:30am - 10:30am CT

The race to develop vaccines to counter the COVID-19 pandemic led to the formation of unique partnerships in the pharmaceutical industry, including cross-border collaborations that leveraged each company’s core capabilities. One of the most successful partnerships was between US-based Pfizer and Germany-based BioNTech, who together created an effective vaccine in record time (9 months compared to the creation of the Ebola vaccine, which took six years).

The success of collaboration in the pharma industry has sparked the question: can companies collaborate further to develop cures/treatments for diseases such as cancer, Alzheimer’s, and HIV?

Join our complimentary webinar on November 9 for the next installment of our Transatlantic Webinar Series: Leading through Crises to learn about the future of partnerships within the biopharma and MedTech industries, and how they can lead to drastic changes in healthcare worldwide. The event format will be a moderated panel discussion with industry experts and will include an interactive Q&A session with the audience.


Main Takeaways:

  • How can cross-border collaboration accelerate the average market launch time for new drugs and other medical technologies as we witnessed during the successful Pfizer-BioNTech collaboration on the COVID-19 vaccine?
  • How can organizations best overcome intercultural and logistical differences that may complicate cross-border collaborations, such as different team leadership styles or project management approaches?
  • What policies can best incentivize private sector innovation while also ensuring affordability and global access to lifesaving medications and treatments?
  • How can companies collaborate across jurisdictions to drive innovation in healthcare forward? What regulatory burdens can policymakers tackle to ease cross-border collaboration?
  • What are best practices for industry start-ups for sourcing funding and running clinical trials in multiple countries concurrently while collaborating with diverse stakeholders using primarily virtual tools?

Follow-Up Workshop:  

As a follow up to this discussion, there will be a private workshop on Thursday, November 18 to engage German and US professionals in a peer-to-peer exchange. If you are interested in participating, please contact Justin Flaxbart.

The project was supported by the Transatlantic Program of the Federal Republic of Germany, funded by the European Recovery Program (ERP) of the Federal Ministry for Economic Affairs and Energy (BMWi).




implemented by